VVN001 Ophthalmic Solution

VVN001 · VivaVision Biotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VVN001 Ophthalmic Solution, covering 2023-02-28 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease [Phase 3]